<scp>VI‐RADS</scp> for Bladder Cancer: Current Applications and Future Developments

Valeria Panebianco(Sapienza University of Rome), Yoshifumi Narumi(Osaka Medical Center for Cancer and Cardiovascular Diseases), Valdair Francisco Muglia(Universidade de São Paulo), Martina Pecoraro(Sapienza University of Rome), Emanuele Messina(Policlinico Umberto I), Stefano Cipollari(Policlinico Umberto I), Carlo Catalano(Unknown), Mitsuru Takeuchi, Francesco Del Giudice(Sapienza University of Rome), Gianluca Giannarini(Ospedale Santa Maria della Misericordia di Udine)
Journal of Magnetic Resonance Imaging
September 17, 2020
10.1002/jmri.27361
Cited by 81

Related Papers

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|618
European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era
|European Urology|2020|313
Urology practice during the COVID-19 pandemic
|Minerva Urologica e Nefrologica|2020|256
Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non–muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection
|European Urology|2019|212
Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic?
|European Urology|2020|206